A Case of Generalized Morphea in the Setting of Aplastic Anemia
Main Article Content
Keywords
Localized scleroderma, Generalized morphea, Aplastic anemia
Abstract
Background: Morphea is a rare sclerosing disorder characterized by the formation of erythematous to violaceous lesions and sclerotic plaques on the skin that can extend to the reticular dermis and subcutaneous tissue. This condition may be associated with pain, pruritus, and limitations in range of motion, causing significant disruption in patients’ quality of life. Similar sclerosing disorders, such as eosinophilic fasciitis and systemic sclerosis, have been associated with hematologic diseases like aplastic anemia (AA). However, few reports of morphea in association with AA have explored this relationship.
Case presentation: A 29-year-old woman with a history of AA presented with pruritic, indurated hyperpigmented plaques on her lower extremities. Her past medical history included congenital aortic stenosis and focal epilepsy. A skin biopsy was consistent with morphea. A concurrent bone marrow biopsy confirmed persistent hypocellularity consistent with AA.
Conclusion: This case highlights a potential immunologic link between morphea and AA given that both diseases involve dysregulated T cell-mediated immune responses. We explore a potential immunologic connection between the two conditions, including the role of chemokines, such as CXCL10, in their pathogenesis. Additionally, we discuss important considerations for physicians when evaluating patients with morphea.
References
2. Wielosz E, Majdan M. Haematological abnormalities in systemic sclerosis. Reumatologia. 2020;58(3):162-166. doi:10.5114/reum.2020.96655
3. de Masson A, Bouaziz JD, de Latour RP, et al. Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature. Medicine (Baltimore). 2013;92(2):69-81. doi:10.1097/MD.0b013e3182899e78
4. Mastrantonio S, Hinds BR, Schneider JA, Sennett R, Cotter DG. An Unusual Case of Morphea in the Setting of Aplastic Anemia. Cureus. 2020;12(4):e7562. Published 2020 Apr 6. doi:10.7759/cureus.7562
5. Tapdia MR, Favas TT, Mishra VN, Pathak A, Singh VK. Generalized Morphea Coincident With Aplastic Anemia: A Case Report. Cureus. 2022;14(1):e20955. Published 2022 Jan 5. doi:10.7759/cureus.20955
6. Antiga E, Quaglino P, Bellandi S, et al. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol. 2010;162(5):1056-1063. doi:10.1111/j.1365-2133.2010.09633.x
7. Ayvaz Celik H, Gurbuz N, Turantepe E, Secme M, Dodurga Y. Profiling of Toll-like Receptors and Related Signaling Mediators in the Pathogenesis of Morphea. Dermatol Pract Concept. 2024;14(4):e2024219. doi: 10.5826/dpc.1404a219
8. Zeng Y, Katsanis E. The complex pathophysiology of acquired aplastic anaemia. Clin Exp Immunol. 2015;180(3):361-370. doi:10.1111/cei.12605
9. Li J, Ge M, Lu S, et al. Pro-inflammatory effects of the Th1 chemokine CXCL10 in acquired aplastic anaemia. Cytokine. 2017;94:45-51. doi:10.1016/j.cyto.2017.04.010
10. Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol. 2009;145(5):545-550. doi:10.1001/archdermatol.2009.79
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.